Global Respiratory Distress Syndrome Competitive Landscape Professional Research Report 2025
Research Summary
Respiratory Distress Syndrome (RDS), also known as hyaline membrane disease, is a serious respiratory condition primarily affecting premature infants. It is characterized by insufficient production of surfactant, a substance that helps keep the air sacs in the lungs open and facilitates breathing. Without adequate surfactant, the infant＇s lungs become stiff, making it difficult for them to expand and contract properly. This results in respiratory difficulties, including rapid breathing, labored breathing, and low oxygen levels in the blood. RDS is most common in infants born before 28 weeks of gestation, as surfactant production usually begins in the third trimester of pregnancy. Treatment often involves providing respiratory support through mechanical ventilation and administering exogenous surfactant. While advancements in neonatal care have improved outcomes, RDS remains a significant challenge in the care of premature infants.
According to DIResearch's in-depth investigation and research, the global Respiratory Distress Syndrome market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Respiratory Distress Syndrome include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Respiratory Distress Syndrome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Respiratory Distress Syndrome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Respiratory Distress Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Respiratory Distress Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Respiratory Distress Syndrome Include:
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Respiratory Distress Syndrome Product Segment Include:
Poractant Alfa
Beractant
Calfactant
Others
Respiratory Distress Syndrome Product Application Include:
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Respiratory Distress Syndrome Industry PESTEL Analysis
Chapter 3: Global Respiratory Distress Syndrome Industry Porter’s Five Forces Analysis
Chapter 4: Global Respiratory Distress Syndrome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Respiratory Distress Syndrome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Respiratory Distress Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Respiratory Distress Syndrome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Respiratory Distress Syndrome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Respiratory Distress Syndrome Product by Type
- 1.2.1 Poractant Alfa
- 1.2.2 Beractant
- 1.2.3 Calfactant
- 1.2.4 Others
- 1.3 Respiratory Distress Syndrome Product by Application
- 1.3.1 Very Preterm Infants
- 1.3.2 Moderate to Late Preterm Infants
- 1.3.3 Others
- 1.4 Global Respiratory Distress Syndrome Market Size Analysis (2020-2032)
- 1.5 Respiratory Distress Syndrome Market Development Status and Trends
- 1.5.1 Respiratory Distress Syndrome Industry Development Status Analysis
- 1.5.2 Respiratory Distress Syndrome Industry Development Trends Analysis
- 2 Respiratory Distress Syndrome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Respiratory Distress Syndrome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Respiratory Distress Syndrome Market Analysis by Regions
- 4.1 Respiratory Distress Syndrome Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Respiratory Distress Syndrome Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Respiratory Distress Syndrome Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Respiratory Distress Syndrome Revenue Forecast by Region (2026-2032)
- 5 Global Respiratory Distress Syndrome Market Size by Type and Application
- 5.1 Global Respiratory Distress Syndrome Market Size by Type (2020-2032)
- 5.2 Global Respiratory Distress Syndrome Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Respiratory Distress Syndrome Market Size by Type
- 6.4 North America Respiratory Distress Syndrome Market Size by Application
- 6.5 North America Respiratory Distress Syndrome Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Respiratory Distress Syndrome Market Size by Type
- 7.4 Europe Respiratory Distress Syndrome Market Size by Application
- 7.5 Europe Respiratory Distress Syndrome Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Respiratory Distress Syndrome Market Size by Type
- 8.4 China Respiratory Distress Syndrome Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Respiratory Distress Syndrome Market Size by Type
- 9.4 APAC (excl. China) Respiratory Distress Syndrome Market Size by Application
- 9.5 APAC (excl. China) Respiratory Distress Syndrome Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Respiratory Distress Syndrome Market Size by Type
- 10.4 Latin America Respiratory Distress Syndrome Market Size by Application
- 10.5 Latin America Respiratory Distress Syndrome Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Respiratory Distress Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Type
- 11.4 Middle East & Africa Respiratory Distress Syndrome Market Size by Application
- 11.5 Middle East & Africa Respiratory Distress Syndrome Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Respiratory Distress Syndrome Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Respiratory Distress Syndrome Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Respiratory Distress Syndrome Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Chiesi Farmaceutici
- 13.1.1 Chiesi Farmaceutici Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Portfolio
- 13.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CR-Double Crane
- 13.2.1 CR-Double Crane Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CR-Double Crane Respiratory Distress Syndrome Product Portfolio
- 13.2.3 CR-Double Crane Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 ONY Biotech
- 13.3.1 ONY Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 ONY Biotech Respiratory Distress Syndrome Product Portfolio
- 13.3.3 ONY Biotech Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 AbbVie
- 13.4.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 AbbVie Respiratory Distress Syndrome Product Portfolio
- 13.4.3 AbbVie Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Yuhan Corporation
- 13.5.1 Yuhan Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Portfolio
- 13.5.3 Yuhan Corporation Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 JW Pharmaceuticals
- 13.6.1 JW Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Portfolio
- 13.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Noargen
- 13.7.1 Noargen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Noargen Respiratory Distress Syndrome Product Portfolio
- 13.7.3 Noargen Respiratory Distress Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Respiratory Distress Syndrome Industry Chain Analysis
- 14.2 Respiratory Distress Syndrome Industry Raw Material and Suppliers Analysis
- 14.2.1 Respiratory Distress Syndrome Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Respiratory Distress Syndrome Typical Downstream Customers
- 14.4 Respiratory Distress Syndrome Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook